BioMedical Enterprises has received clearance from the U.S. Food and Drug Administration on an upgrade to its patent-pending Hammerlock Intramedullary Fixation System for hammertoe deformities, according to a news release.
Upgrades to the HammerLock include a linear body that allows for easier bone fusion, better flexibility in positioning the device and easier insertion.
The system uses the metal Nitinol, an alloy of nickel and titanium, for its shape memory properties. It does not use any wires.
More Articles on FDA Regulations:
FDA Recalls Spacelabs Healthcare's Anesthesia Workstations
FDA Orders 23andMe to Stop Sale of Personal Genome Service
OrthAlign Receives 510(k) FDA Clearance for ORTHALIGN PLUS System